HOME>Research&Development>Clinical Trial Information

Clinical Trial Information

For information on the clinical trials that our company conducts both domestically in Japan and overseas, and for which publication in international medical journals is scheduled, clinical trial information is registered on ClinicalTrials.gov (the website run by the United States National Library of Medicine), EU Clinical Trials Register (the website run by European Medicines Agency), or JapicCTI (the website run by the Japan Pharmaceutical Information Center).

Links:
ClinicalTrials.gov
Japan Pharmaceutical Information Center
EU Clinical Trials Register

Please use the links provided below to view our company listing on Clinical Trials.gov.

  • RSS
  • About RSS

Prev.20 | 1 | 2 | 3 | 4 | 5 | Next 20

ClinicalTrials.gov ID NCT03188692 (2017/6 Update)
Study Title Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
ClinicalTrials.gov ID NCT03176771 (2017/6 Update)
Study Title Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
ClinicalTrials.gov ID NCT03172598 (2017/5 Entry)
Study Title Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy
ClinicalTrials.gov ID NCT02992925 (2016/12 Entry)
Study Title Phase 3 Study of BK1310 in Healthy Infants
ClinicalTrials.gov ID NCT02923154 (2016/10 Entry)
Study Title Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
ClinicalTrials.gov ID NCT02924064 (2016/10 Entry)
Study Title Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov ID NCT02916706(2016/9 Entry)
Study Title Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov ID NCT02803268(2017/2 Update)※This study has been completed.
Study Title A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms
ClinicalTrials.gov ID NCT02676401(2016/2 Entry)
Study Title An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy
ClinicalTrials.gov ID NCT02622113(2016/7 Update)※This study has been completed.
Study Title Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov ID NCT02517320(2017/3 Update)※This study has been completed.
Study Title Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
ClinicalTrials.gov ID NCT02389790(2015/3 Entry)
Study Title Extension Study of MT-1303 in Subjects With Crohn's Disease
ClinicalTrials.gov ID NCT02378688(2016/10 Update)※This study has been completed.
Study Title Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
ClinicalTrials.gov ID NCT02354222(2016/8 Update)※This study has been completed.
Study Title Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
ClinicalTrials.gov ID NCT02354235(2016/8 Update)※This study has been completed.
Study Title Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
ClinicalTrials.gov ID NCT02314637(2015/8 Update)※This study has been completed.
Study Title Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
ClinicalTrials.gov ID NCT02307643(2017/6 Update)※This study has been completed.
Study Title Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients
ClinicalTrials.gov ID NCT02227849(2016/7 Update)※This study has been completed.
Study Title Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov ID NCT02220907(2016/8 Update)※This study has been completed.
Study Title Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
ClinicalTrials.gov ID NCT02220920(2016/12Update)※This study has been completed.
Study Title Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

Prev.20 | 1 | 2 | 3 | 4 | 5 | Next 20

Research&Development

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide